BR0210342A - Goma de mascar revestida contendo nicotina e fabricação e uso da mesma - Google Patents

Goma de mascar revestida contendo nicotina e fabricação e uso da mesma

Info

Publication number
BR0210342A
BR0210342A BR0210342-7A BR0210342A BR0210342A BR 0210342 A BR0210342 A BR 0210342A BR 0210342 A BR0210342 A BR 0210342A BR 0210342 A BR0210342 A BR 0210342A
Authority
BR
Brazil
Prior art keywords
nicotine
coated
chewing gum
manufacture
forms
Prior art date
Application number
BR0210342-7A
Other languages
English (en)
Inventor
Katarina Lindell
Nils-Olof Lindberg
Roland Olsson
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Publication of BR0210342A publication Critical patent/BR0210342A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G4/00—Chewing gum
    • A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
    • A23B4/00—Preservation of meat, sausages, fish or fish products
    • A23B4/10—Coating with a protective layer; Compositions or apparatus therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G4/00—Chewing gum
    • A23G4/02—Apparatus specially adapted for manufacture or treatment of chewing gum
    • A23G4/04—Apparatus specially adapted for manufacture or treatment of chewing gum for moulding or shaping
    • A23G4/043—Apparatus specially adapted for manufacture or treatment of chewing gum for moulding or shaping for composite chewing gum
    • A23G4/046—Apparatus specially adapted for manufacture or treatment of chewing gum for moulding or shaping for composite chewing gum with a centre made of chewing gum
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G4/00—Chewing gum
    • A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
    • A23G4/12—Chewing gum characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
    • A23G4/126—Chewing gum characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins containing vitamins, antibiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G4/00—Chewing gum
    • A23G4/18—Chewing gum characterised by shape, structure or physical form, e.g. aerated products
    • A23G4/20—Composite products, e.g. centre-filled, multi-layer, laminated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Addiction (AREA)
  • Microbiology (AREA)
  • Psychiatry (AREA)
  • Physiology (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Confectionery (AREA)

Abstract

"GOMA DE MASCAR REVESTIDA CONTENDO NICOTINA E FABRICAçãO E USO DA MESMA". A presente invenção se refere a um produto de goma de mascar revestida para liberação de nicotina em quaisquer de suas formas a uma pessoa, mediante rápida absorção transmucosal na cavidade oral, compreendendo pelo menos um núcleo de goma, nicotina em quaisquer de suas formas e/ou um agente imitativo de nicotina, pelo menos uma camada de revestimento e, opcionalmente, pelo menos um ou mais aditivos, em que a dita pelo menos uma camada de revestimento é tamponada. A invenção também contempla um método para a liberação de nicotina em quaisquer de suas formas, um método para redução da ansiedade de fumar ou de utilizar o fumo, assim como, um método para produzir a dita goma de mascar revestida e o uso da mesma, de modo a se obter uma rápida absorção transmucosal da nicotina na cavidade oral de uma pessoa.
BR0210342-7A 2001-06-20 2002-06-14 Goma de mascar revestida contendo nicotina e fabricação e uso da mesma BR0210342A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0102197A SE0102197D0 (sv) 2001-06-20 2001-06-20 New product and use and manufacture thereof
PCT/SE2002/001158 WO2002102357A1 (en) 2001-06-20 2002-06-14 A coated nicotine-containing chewing gum, manufacture and use thereof

Publications (1)

Publication Number Publication Date
BR0210342A true BR0210342A (pt) 2004-07-13

Family

ID=20284551

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0210342-7A BR0210342A (pt) 2001-06-20 2002-06-14 Goma de mascar revestida contendo nicotina e fabricação e uso da mesma

Country Status (19)

Country Link
US (2) US20040194793A1 (pt)
EP (1) EP1404306B1 (pt)
JP (2) JP4571402B2 (pt)
AR (1) AR034527A1 (pt)
AT (1) ATE485034T1 (pt)
AU (1) AU2002345454B2 (pt)
BR (1) BR0210342A (pt)
CA (1) CA2449298C (pt)
CZ (1) CZ20033458A3 (pt)
DE (1) DE60238054D1 (pt)
DK (1) DK1404306T3 (pt)
ES (1) ES2352681T3 (pt)
IL (2) IL159425A0 (pt)
MX (1) MXPA03011557A (pt)
NZ (1) NZ529780A (pt)
RU (1) RU2291688C2 (pt)
SE (1) SE0102197D0 (pt)
WO (1) WO2002102357A1 (pt)
ZA (1) ZA200309204B (pt)

Families Citing this family (90)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1578422B1 (en) 2002-12-20 2007-04-11 NicoNovum AB A physically and chemically stable nicotine and micorcrystalline cellulose containing particulate material
SE0302947D0 (sv) 2003-01-24 2003-11-07 Magle Ab A composition material for transmucosal delivery
JP5283334B2 (ja) * 2003-01-24 2013-09-04 マグル ホールディング エービー 経粘膜伝達用組成物材料
EP1797769A3 (en) * 2003-02-04 2012-03-07 Gumlink A/S Compressed chewing gum tablet
EP1449525A1 (en) * 2003-02-20 2004-08-25 Cross Chem Llc chewing gum in the form of multi-layer tablets
US20070191815A1 (en) 2004-09-13 2007-08-16 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery
DE602005015446D1 (de) * 2004-06-29 2009-08-27 Fertin Pharma As Tabakalkaloid freisetzendes kaugummi
BRPI0513465B1 (pt) * 2004-08-11 2015-08-11 Intercontinental Great Brands Llc Composições orais, artigo comestível, composições para balas e goma de mascar, métodos para preparação do referido artigo e para fornercer sensação às áreas receptoras orais
US8252321B2 (en) 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
JP2008515407A (ja) 2004-10-08 2008-05-15 ガムリンク エー／エス 菓子製品
EP1817014B1 (en) 2004-11-30 2012-08-22 Fertin Pharma A/S Method of providing fast relief to a user of a nicotine chewing gum
US8323683B2 (en) * 2005-05-18 2012-12-04 Mcneil-Ppc, Inc. Flavoring of drug-containing chewing gums
US8709502B2 (en) * 2005-09-23 2014-04-29 Chanel Parfums Beaute Extract of Vanilla planifolia
US8024911B2 (en) 2006-02-16 2011-09-27 Mcneil Ab Method for blister packing
US9402809B2 (en) 2006-03-16 2016-08-02 Niconovum Usa, Inc. Snuff composition
AU2007224586A1 (en) * 2006-03-16 2007-09-20 Niconovum Ab Stable lozenge compositions providing rapid release of nicotine
US20070269492A1 (en) * 2006-05-16 2007-11-22 Per Steen New product and use and manufacture thereof
US20070269386A1 (en) 2006-05-16 2007-11-22 Per Steen New product and use and manufacture thereof
AU2012241150B2 (en) * 2006-07-21 2015-04-16 Jsrnti, Llc Medicinal delivery system and related methods
US8642016B2 (en) * 2006-07-21 2014-02-04 Jsrnti, Llc Medicinal delivery system, and related methods
RU2476076C2 (ru) * 2007-02-26 2013-02-27 Револимер Лимитед Лечебная жевательная резинка
EP1977746B8 (en) * 2007-04-02 2014-09-24 Parkinson's Institute Methods and compositions for reduction of side effects of therapeutic treatments
US20080286340A1 (en) * 2007-05-16 2008-11-20 Sven-Borje Andersson Buffered nicotine containing products
US20080286341A1 (en) * 2007-05-16 2008-11-20 Sven-Borje Andersson Buffered coated nicotine containing products
CA2699806A1 (en) * 2007-09-18 2009-03-26 Niconovum Ab Stable chewing gum compositions comprising maltitol and providing rapid release of nicotine
JP2009102287A (ja) * 2007-10-19 2009-05-14 Seiji Sakao 禁煙用の辛い唐辛子
WO2009080022A1 (en) * 2007-12-20 2009-07-02 Fertin Pharma A/S Compressed chewing gum tablet
EP2229157B1 (en) 2007-12-20 2016-08-10 Fertin Pharma A/S Compressed chewing gum tablet
DK2229156T3 (en) 2007-12-20 2017-02-06 Fertin Pharma As CHEW GUM TABLE AND PROCEDURE FOR DOSING PHARMACEUTICAL ACTIVE INGREDIENTS IN SUCH CHEW GUM TABLE
RU2367472C1 (ru) * 2008-03-17 2009-09-20 Общество С Ограниченной Ответственностью "Технология Лекарств" Парентеральное лекарственное средство и способ его получения
CL2009001025A1 (es) 2008-05-01 2010-09-24 Smithkline Beecham Corp Composicion de pastilla para chupar que comprende: a) un granulo patron con al menos: un agente tampon alcalino, un modificador de la disolucion y una carga, b) un principio activo de nicotina definido extragranular y al menos un agente tampon alcalino; procedimiento de preparacion; util para eliminar o reducir el uso de tabaco.
EP2293786B1 (en) * 2008-05-21 2014-11-26 Novartis AG Tablettable chewing gums comprising nicotine and a buffering agent
EP2282645B1 (en) 2008-05-26 2015-04-15 Fertin Pharma A/S Flavor impregnation of a chewing gum core
US9700525B2 (en) 2008-08-20 2017-07-11 Board Of Supervisors Of Louisiana State University And Agricultural & Mechanical College Continuous local slow-release of therapeutics for head and neck problems and upper aerodigestive disorders
US8833378B2 (en) * 2008-09-17 2014-09-16 Niconovum Ab Process for preparing snuff composition
PT2361081T (pt) * 2008-10-14 2016-09-05 Mcneil Ab Forma de dosagem intra-oral multiporção e seu uso
US8506936B2 (en) * 2008-11-25 2013-08-13 Watson Laboratories, Inc. Stabilized nicotine chewing gum
BRPI0922172A2 (pt) * 2008-12-19 2015-12-29 Us Smokeless Tobacco Co produto de tabaco sem fumaça, e, processo para fabricar um produto de tabaco
WO2010069311A1 (en) 2008-12-19 2010-06-24 Fertin Pharma A/S Multi-part kit
EP2233134A1 (en) * 2009-03-27 2010-09-29 McNeil AB Multi-portion intra-oral dosage form with organoleptic properties
EP2442668B1 (en) 2009-06-19 2016-08-10 Fertin Pharma A/S Buffered gum base for high ph release
RU2417095C1 (ru) * 2010-02-12 2011-04-27 Александр Ицхокович Кашлинский Средство "куримало" ("км"), снижающее тягу к курению
US20110268809A1 (en) 2010-04-28 2011-11-03 Paul Andrew Brinkley Nicotine-Containing Pharmaceutical Compositions
US20110274628A1 (en) 2010-05-07 2011-11-10 Borschke August J Nicotine-containing pharmaceutical compositions
US8529914B2 (en) * 2010-06-28 2013-09-10 Richard C. Fuisz Bioactive dose having containing a material for modulating pH of a bodily fluid to help or hinder absorption of a bioactive
US20130017259A1 (en) 2011-07-06 2013-01-17 The Parkinson's Institute Compositions and Methods for Treatment of Symptoms in Parkinson's Disease Patients
CA2852788C (en) 2011-10-19 2019-02-12 Fertin Pharma A/S Nicotine chewing gum with improved utilization of nicotine
US9907748B2 (en) 2011-10-21 2018-03-06 Niconovum Usa, Inc. Excipients for nicotine-containing therapeutic compositions
US20130177646A1 (en) * 2012-01-05 2013-07-11 Mcneil Ab Solid Nicotine-Comprising Dosage Form with Reduced Organoleptic Disturbance
US10105487B2 (en) 2013-01-24 2018-10-23 Chrono Therapeutics Inc. Optimized bio-synchronous bioactive agent delivery system
US10130120B2 (en) 2013-03-15 2018-11-20 Altria Client Services Llc Use of pectin or other anionic polymers in the stabilization and controlled release of nicotine in oral sensorial tobacco products or nicotine containing non-tobacco oral sensorial products
WO2015009862A2 (en) * 2013-07-19 2015-01-22 Altria Client Services Inc. Liquid aerosol formulation of an electronic smoking article
CN103478893B (zh) * 2013-09-09 2016-02-10 湖南中烟工业有限责任公司 茶氨酸在胶基咀嚼型无烟气烟草制品中的应用
EP3129011B1 (en) 2014-04-08 2023-06-07 Fertin Pharma A/S Medical chewing gum
US9744128B2 (en) 2014-06-05 2017-08-29 Mastix LLC Method for manufacturing medicated chewing gum without cooling
JP2018511355A (ja) 2015-01-28 2018-04-26 クロノ セラピューティクス インコーポレイテッドＣｈｒｏｎｏ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． 薬剤送達方法及びシステム
AU2016228779A1 (en) 2015-03-12 2017-09-07 Chrono Therapeutics Inc. Craving input and support system
US20170165252A1 (en) 2015-12-10 2017-06-15 Niconovum Usa Inc. Protein-enriched therapeutic composition
ES2814296T3 (es) 2016-04-21 2021-03-26 Fertin Pharma As Producto para administración de nicotina, usos relacionados y formas de dosificación oral y métodos de producción
US10765658B2 (en) 2016-06-22 2020-09-08 Mastix LLC Oral compositions delivering therapeutically effective amounts of cannabinoids
US10632076B2 (en) 2016-11-18 2020-04-28 Fertin Pharma A/S Tablet comprising separate binder and erythritol
US10543205B2 (en) 2016-11-18 2020-01-28 Fertin Pharma A/S Oral delivery vehicle containing nicotine
WO2018129304A1 (en) 2017-01-06 2018-07-12 Chrono Therapeutics Inc. Transdermal drug delivery devices and methods
SE541358C2 (en) 2017-05-30 2019-08-13 Enorama Pharma Ab Nicotine-containing chewing gum compositions
US11135157B2 (en) 2018-05-17 2021-10-05 Fertin Pharma A/S Oral tablet for delivery of active ingredients to the throat
US11096894B2 (en) 2018-05-17 2021-08-24 Fertin Pharma A/S Oral tablet for induced saliva generation
US11090263B2 (en) 2018-05-22 2021-08-17 Fertin Pharma A/S Tableted chewing gum suitable for active pharmaceutical ingredients
US11096896B2 (en) 2018-05-17 2021-08-24 Fertin Pharma A/S Tablet dosage form for buccal absorption of active ingredients
US11058633B2 (en) 2018-05-17 2021-07-13 Fertin Pharma A/S Disintegrating oral tablet suitable for active pharmaceutical ingredients
US11052047B2 (en) 2018-05-17 2021-07-06 Fertin Pharma A/S Oral tablet suitable for fast release of active pharmaceutical ingredients
US11058641B2 (en) 2018-05-17 2021-07-13 Fertin Pharma A/S Oral tablet for taste masking of active ingredients
MX2020012265A (es) * 2018-05-17 2021-01-29 Fertin Pharma As Goma de mascar en tabletas adecuada para ingredientes farmaceuticos activos.
US11096895B2 (en) 2018-05-17 2021-08-24 Fertin Pharma A/S Oral tablet suitable for active pharmaceutical ingredients
US20190350858A1 (en) 2018-05-17 2019-11-21 Fertin Pharma A/S Oral tablet for delivery of active ingredients to the gastrointestinal tract
AU2019279884B2 (en) 2018-05-29 2025-01-30 Morningside Venture Investments Limited Drug delivery methods and systems
DK3807260T3 (da) 2018-06-15 2024-10-14 Reynolds Tobacco Co R Oprensning af nikotin
WO2020012009A1 (en) * 2018-07-13 2020-01-16 Mcneil Ab Chewing gum comprising nicotine
CN108991596B (zh) * 2018-10-11 2020-07-28 玉溪开元金蓝生物科技有限责任公司 复方滇橄榄添加料、制备方法及其在香烟滤嘴棒上的应用
GB201817859D0 (en) * 2018-11-01 2018-12-19 Nicoventures Trading Ltd Aerosolisable formulation
IL262768B (en) 2018-11-04 2020-08-31 Ambrosia Supherb Ltd A chewable tablet and method of preparing the same
JP2022507660A (ja) 2018-11-16 2022-01-18 モーニングサイド ベンチャー インベストメンツ リミテッド 温度によって調節される経皮薬剤送達システム
CA3167795A1 (en) * 2020-01-15 2021-07-22 Mcneil Ab Product and manufacturing process for a gum
BR112022013153A2 (pt) * 2020-01-15 2022-10-18 Mcneil Ab Produto e método para a fabricação de uma goma
LT4243797T (lt) * 2020-11-16 2026-06-10 Orcosa Inc. Greitos infuzijos platforma ir kompozicijos, skirtos žmonių terapiniam gydymui
USD1081739S1 (en) 2021-04-06 2025-07-01 Altria Client Services Llc Die for gum forming
MX2023012537A (es) * 2021-04-22 2024-01-24 Nicoventures Trading Ltd Composiciónes orales y metodos de fabricacion.
US12295412B2 (en) 2022-01-28 2025-05-13 Altria Client Services Llc Oral pouch product
CN116570027A (zh) * 2023-06-15 2023-08-11 东莞市吉纯生物技术有限公司 一种含有辣椒素提取物的口含制品及其制备方法
CN117158634A (zh) * 2023-09-27 2023-12-05 东莞市吉纯生物技术有限公司 卷烟制品、烟碱盐及其制备方法、发烟材料及其制备方法
SE547629C2 (en) * 2024-01-18 2025-10-28 Vont Ab Natural chewing gum with nicotine and manufacturing method

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3901248A (en) 1970-07-22 1975-08-26 Leo Ab Chewable smoking substitute composition
US3877468A (en) 1970-07-22 1975-04-15 Leo Ab Chewable tobacco substitute composition
US3845217A (en) * 1972-11-16 1974-10-29 Helsingborg L Ab Buffered smoking substitute compositions
US4366211A (en) 1981-09-21 1982-12-28 Westinghouse Electric Corp. Control of electrolyte fill to fuel cell stack
GB8301659D0 (en) * 1983-01-21 1983-02-23 Leo Ab Smoking substitutes
US4920989A (en) * 1985-04-25 1990-05-01 Regents Of The University Of California Method and apparatus for aiding in the reduction of incidence of tobacco smoking
GB8615676D0 (en) * 1986-06-26 1986-07-30 Stoppers Co Ltd Nicotine containing lozenge
US5057328A (en) * 1988-11-14 1991-10-15 Warner-Lambert Company Food acid delivery systems containing polyvinyl acetate
US5154939A (en) * 1989-04-19 1992-10-13 Wm. Wrigley Jr. Company Use of salt to improve extrusion encapsulation of chewing gum ingredients
US5167242A (en) * 1990-06-08 1992-12-01 Kabi Pharmacia Aktiebolaq Nicotine-impermeable container and method of fabricating the same
GB9200047D0 (en) * 1992-01-03 1992-02-26 Univ Alberta Nicotine-containing nasal spray
US6024097A (en) * 1992-02-20 2000-02-15 J Mom Trust Product for assisting a smoker in giving up the habit
US5869505A (en) * 1993-02-02 1999-02-09 Keenan; Robert M. Nicotine metabolites and nicotine dependence
US5549906A (en) * 1993-07-26 1996-08-27 Pharmacia Ab Nicotine lozenge and therapeutic method for smoking cessation
US5362496A (en) * 1993-08-04 1994-11-08 Pharmetrix Corporation Method and therapeutic system for smoking cessation
SE9303574D0 (sv) * 1993-11-01 1993-11-01 Kabi Pharmacia Ab Composition for drug delivery and method the manufacturing thereof
GB2289204B (en) * 1994-04-21 1998-01-14 Williamson Research Limited A chewing gum for use as a nicotine substitute and slimming aid
US5810018A (en) * 1994-12-29 1998-09-22 Monte; Woodrow C. Method, composition and apparatus for reducing the incidence of cigarette smoking
ATE300937T1 (de) * 1995-05-11 2005-08-15 Univ Utah Res Found Tabakersatz
US5955098A (en) * 1996-04-12 1999-09-21 Flemington Pharmaceutical Corp. Buccal non polar spray or capsule
TR199802305T2 (xx) * 1996-05-13 2002-06-21 Norvartis Consumer Health S.A. Yanaktan uygulama y�ntemi.
DE19639342C2 (de) * 1996-09-25 1998-07-16 Suedzucker Ag Kaugummi, enthaltend ein Süßungsmittel
DE69636292T2 (de) 1996-11-27 2007-06-28 Wm. Wrigley Jr. Co., Chicago Verfahren zur kontrollierten abgabe von koffein in kaugummi sowie so hergestelltes kaugummi
WO2000035298A1 (en) 1996-11-27 2000-06-22 Wm. Wrigley Jr. Company Chewing gum containing medicament active agents
US6413496B1 (en) * 1996-12-04 2002-07-02 Biogland Ireland (R&D) Limited Pharmaceutical compositions and devices for their administration
SE9703458D0 (sv) * 1997-09-25 1997-09-25 Pharmacia & Upjohn Ab Nicotine compositions and methods of formulation thereof
CA2346330C (en) 1998-09-03 2011-10-04 Jsr Llc Medicated chewing gum delivery system for nicotine
WO2000019977A1 (en) 1998-10-08 2000-04-13 Biovail Technologies Ltd. Composition and method for medicated chewing gum delivery system
US6586023B1 (en) * 1998-12-15 2003-07-01 Wm. Wrigley Jr. Company Process for controlling release of active agents from a chewing gum coating and product thereof
WO2000056281A1 (en) * 1999-03-22 2000-09-28 Atp Avant-Garde Technologies & Product Marketing & Licensing S.A. Composition for medicated chewing gums, process for manufacturing the same and tablets so obtained

Also Published As

Publication number Publication date
IL159425A0 (en) 2004-06-01
CA2449298C (en) 2011-08-02
CA2449298A1 (en) 2002-12-27
EP1404306A1 (en) 2004-04-07
NZ529780A (en) 2006-04-28
JP2010070564A (ja) 2010-04-02
RU2003137595A (ru) 2005-02-10
ATE485034T1 (de) 2010-11-15
WO2002102357A1 (en) 2002-12-27
EP1404306B1 (en) 2010-10-20
IL159425A (en) 2006-12-10
RU2291688C2 (ru) 2007-01-20
US20040194793A1 (en) 2004-10-07
ZA200309204B (en) 2005-02-23
US20120017924A1 (en) 2012-01-26
ES2352681T3 (es) 2011-02-22
MXPA03011557A (es) 2004-03-18
JP2005500296A (ja) 2005-01-06
DK1404306T3 (da) 2011-01-24
CZ20033458A3 (en) 2004-05-12
SE0102197D0 (sv) 2001-06-20
AU2002345454B2 (en) 2006-07-20
AR034527A1 (es) 2004-02-25
JP4571402B2 (ja) 2010-10-27
DE60238054D1 (de) 2010-12-02

Similar Documents

Publication Publication Date Title
AR034527A1 (es) Nuevo producto y uso y fabricacion del mismo
BR0109729A (pt) Uso de uma combinação de um agente anti-angiogênico e um agente anti-hipertensivo, kit para uso na produção de um efeito anti-angiogênico e/ou efeito redutor da permeabilidade vascular em um animal de sangue quente, e, método de tratamento de um estado doentio associado com a angiogênese
SE0201669D0 (sv) New formulation and use thereof
BR0313526A (pt) Medicamento inalativos que contêm um agente anticolinérigo, em combinação com corticoesteróides e betamiméticos
BR0209986A (pt) Agonista de a2a em combinação com um agente anticolinérgico, para o tratamento de doenças obstrutivas das vias respiratórias
BRPI0513917A (pt) métodos para formar um filtro aromatizado para um artigo para fumar, e para fornecer um filtro de artigo para fumar com aroma, artigo para fumar, e, filtro para um artigo para fumar
DE60231835D1 (de) Flüssige pharmazeutische zusammesetzung mit nikotin zur verabreichung in die mundhöhle
BR0102468A (pt) Recipiente de vidro laminado de chumbo/âmbar emétodo de produção do mesmo
BRPI0114927B8 (pt) composição de gel farmacêutica não aquosa para aplicação na pele, e, uso de uma composição
ATE515953T1 (de) Rauchartikel mit konzentrischem hohlem kern in einem tabakstab sowie kapsel mit duftmittel- und aerosolbildungsmitteln im filtersystem
ATE381926T2 (de) Vitaminzusammenstellung mit verzögerter freigabe
BR0010456A (pt) Uso de xenÈnio para tratar neurointoxicações, preparação inalável e método para produzir uma preparação inalável
DK1131071T3 (da) Nikotin-indeholdende farmaceutiske sammensætninger givende en hurtig transmukosale absorption
BR0109672A (pt) Uso de zd6126 ou de um seu sal farmaceuticamente aceitável e um de: um agente antitumoral de plantina e um taxano, composição farmacêutica, produto de combinação, kit, e, método para a produção de um efeito de danificação vascular em um animal de sangue quente
ES2162614T1 (es) Composiciones formadoras de pelicula que comprenden almidones modificados e iota-carragaenina y metodo para producir capsulas blandas usando las mismas.
BR0112495A (pt) Forma de dosagem, processo para a produção de uma forma de dosagem e uso da forma de dosagem
MEP40008A (en) Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament
WO2005053719A3 (en) Compositions for the treatment of diseases of the oral cavity and upper respiratory tract
BRPI0208411B8 (pt) composto, composição farmacêutica tópica para tratamento profilático ou terapêutico de doenças sexualmente transmitidas em um paciente humano, e, uso de um composto
BRPI0409935A (pt) composição para aperfeiçoar percepção e memória
BR0309085A (pt) Medicamento que contém esteróides e agente anticolinérgico
BR0206979A (pt) Métodos e composições para reduzir o paladar de agentes farmaceuticamente ativos
AR047480A1 (es) Composicion para la prevencion y/o tratamiento de enfermedades metabolicas oseas; proceso de preparacion y uso de esta composicion
ATE323464T1 (de) Verwendung des dheas oder bestimmte seiner derivaten zur verbesserung des papyrus-ähnliches aussehens der haut
BR0313224A (pt) Composição farmacêutica contendo composto para terapia da disfunção sexual para ser administrada de modo oral que proporciona rápido inìcio de seus efeitos farmacológicos

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: A61K 9/68, 31/465; A61P 25/34, 43/00

Ipc: A61K 9/68 (2011.01), A61K 31/465 (2011.01), A61P 2

B15V Prolongation of time limit allowed

Free format text: RECONHECIDO O OBSTACULO ADMINISTRATIVO E DEVOLVIDO O PRAZO DE 30 DIAS PARA CUMPRIMENTO DE EXIGENCIA, NOS TERMOS DO ARTIGO 221 PARAGRAFO 2O DA LPI E DA RESOLUCAO 116/04.

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]